A detailed history of Haverford Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Haverford Trust CO holds 755,212 shares of MRK stock, worth $75 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
755,212
Previous 809,377 6.69%
Holding current value
$75 Million
Previous $100 Million 14.41%
% of portfolio
0.84%
Previous 1.06%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$111.15 - $128.97 $6.02 Million - $6.99 Million
-54,165 Reduced 6.69%
755,212 $85.8 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $1.49 Million - $1.61 Million
-12,073 Reduced 1.47%
809,377 $100 Million
Q1 2024

May 02, 2024

BUY
$113.24 - $131.95 $814,308 - $948,852
7,191 Added 0.88%
821,450 $108 Million
Q4 2023

Feb 08, 2024

BUY
$100.18 - $109.02 $587,054 - $638,857
5,860 Added 0.72%
814,259 $88.8 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $2.73 Million - $3.04 Million
-26,565 Reduced 3.18%
808,399 $83.2 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $773,085 - $842,628
-7,118 Reduced 0.85%
834,964 $96.3 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $14.3 Million - $15.9 Million
-138,489 Reduced 14.12%
842,082 $89.6 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $336,731 - $431,735
-3,851 Reduced 0.39%
980,571 $109 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.45 Million - $1.63 Million
17,143 Added 1.77%
984,422 $84.8 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $319,516 - $362,187
3,827 Added 0.4%
967,279 $88.2 Million
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $4.4 Million - $4.93 Million
59,841 Added 6.62%
963,452 $79.1 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $2.04 Million - $2.56 Million
28,248 Added 3.23%
903,611 $69.3 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $2.09 Million - $2.3 Million
29,146 Added 3.44%
875,363 $65.7 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $54.9 Million - $60.7 Million
780,407 Added 1185.85%
846,217 $65.8 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $51.8 Million - $57.3 Million
-736,888 Reduced 91.8%
65,810 $65.8 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $7.93 Million - $9.34 Million
115,181 Added 16.75%
802,698 $61.9 Million
Q4 2020

Feb 05, 2021

BUY
$71.77 - $79.65 $1.5 Million - $1.67 Million
20,933 Added 3.14%
687,517 $56.2 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $3.68 Million - $4.17 Million
50,242 Added 8.15%
666,584 $55.3 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $2.96 Million - $3.37 Million
41,999 Added 7.31%
616,342 $47.7 Million
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $2.44 Million - $3.38 Million
38,495 Added 7.18%
574,343 $44.2 Million
Q4 2019

Feb 10, 2020

SELL
$77.58 - $87.54 $77,890 - $87,890
-1,004 Reduced 0.19%
535,848 $48.7 Million
Q3 2019

Nov 04, 2019

BUY
$76.08 - $82.93 $612,063 - $667,171
8,045 Added 1.52%
536,852 $45.2 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $343,822 - $401,667
4,923 Added 0.94%
528,807 $44.3 Million
Q1 2019

May 09, 2019

BUY
$69.58 - $79.36 $658,018 - $750,507
9,457 Added 1.84%
523,884 $43.6 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $465,487 - $540,190
-7,135 Reduced 1.37%
514,427 $39.3 Million
Q3 2018

Nov 08, 2018

SELL
$57.69 - $67.84 $324,506 - $381,600
-5,625 Reduced 1.07%
521,562 $37 Million
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $413,705 - $486,061
-8,139 Reduced 1.52%
527,187 $32 Million
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $9.24 Million - $10.7 Million
-181,221 Reduced 25.29%
535,326 $29.2 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $182,838 - $218,328
3,542 Added 0.5%
716,547 $40.3 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $499,223 - $537,173
8,509 Added 1.21%
713,005 $45.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
704,496
704,496 $45.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.